Impact of anti-CD20 monoclonal antibodies on serologic response to

Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells

Breadth and function of antibody response to acute SARS-CoV-2 infection in humans

Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises

Neutralizing antibody against anti–SARS-CoV-2 vaccination

Anti-CD20 monoclonal antibodies and associated viral hepatitis in hematological diseases

The effects of type I and type II anti-CD20 mAb binding to CD20 on

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

Production of anti-spike antibodies in response to COVID vaccine in lymphoma patients

Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis - eBioMedicine

Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma